Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 72, Issue 9, 2013, Pages 1549-1558

  Alexander, Tobias ^a,b   Sattler, Arne ^a   Templin, Lars ^a   Kohler, Siegfried ^a   Groß, Christian ^a   Meisel, Andreas ^a   Sawitzki, Birgit ^a   Burmester, Gerd Rüdiger ^a   Arnold, Renate ^a   Radbruch, Andreas ^b   Thiel, Andreas ^a   Hiepe, Falk ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GAMMA INTERFERON; HELIOS TRANSCRIPTION FACTOR; IKAROS TRANSCRIPTION FACTOR; INTERLEUKIN 2; KI 67 ANTIGEN; PREDNISOLONE; STAT5A PROTEIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DEMETHYLATION; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; GRANULOMATOSIS; HUMAN; HUMAN CELL; JOINT PROSTHESIS; LYMPHOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; METHYLATION; MYASTHENIA GRAVIS; OSTEOARTHRITIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THYMECTOMY;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELLS;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE SILENCING; HUMANS; IKAROS TRANSCRIPTION FACTOR; IMMUNOPHENOTYPING; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; T-LYMPHOCYTES, REGULATORY;

EID: 84881432074     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202216     Document Type: Article

References (43)

1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med 2011;365:2110-21.
2. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012;30:531-64.
3. Scheinecker C, Bonelli M, Smolen JS. Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells. J Autoimmun 2010;35:269-75.
4. Valencia X, Yarboro C, Illei G, et al. Deficient CD4+CD25 high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007;178:2579-88. (Pubitemid 46233461)
5. Venigalla RK, Tretter T, Krienke S, et al. Reduced CD4+. Arthritis Rheum 2008;58:2120-30.
6. Bonelli M, von DK, Savitskaya A, et al. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis. Ann Rheum Dis 2008;67:664-71. (Pubitemid 351571931)
7. Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003;21:273-6. (Pubitemid 37410115)
8. Bonelli M, Savitskaya A, von DK, et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int Immunol 2008;20:861-8. (Pubitemid 351876312)
9. Chavele KM, Ehrenstein MR. Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis. FEBS Lett 2011;585:3603-10.
10. Miyara M, Amoura Z, Parizot C, et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005;175:8392-400. (Pubitemid 41798406)
11. Pillai V, Ortega SB, Wang CK, et al. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 2007;123:18-29. (Pubitemid 46401504)
12. Gavin MA, Torgerson TR, Houston E, et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 2006;103:6659-64.
13. Fontenot JD, Rasmussen JP, Williams LM, et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005;22:329-41. (Pubitemid 40387475)
14. Hill JA, Feuerer M, Tash K, et al. Foxp3 transcription-factor-dependent and-independent regulation of the regulatory T cell transcriptional signature. Immunity 2007;27:786-800. (Pubitemid 350110546)
15. Thornton AM, Korty PE, Tran DQ, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3 + T regulatory cells. J Immunol 2010;184:3433-41.
16. Verhagen J, Wraith DC. Comment on "Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3 + T regulatory cells". J Immunol 2010;185:7129.
17. Akimova T, Beier UH, Wang L, et al. Helios expression is a marker of T cell activation and proliferation. PLoS One 2011;6:e24226.
18. Gottschalk RA, Corse E, Allison JP. Expression of Helios in peripherally induced Foxp3+ regulatory T cells. J Immunol 2012;188:976-80.
19. Getnet D, Grosso JF, Goldberg MV, et al. A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells. Mol Immunol 2010;47:1595-600.
20. Zabransky DJ, Nirschl CJ, Durham NM, et al. Phenotypic and functional properties of helios(+) regulatory T cells. PLoS One 2012;7:e34547.
21. Kim YC, Bhairavabhotla R, Yoon J, et al. Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansion. Blood Published Online First: 31 Jan 2012. doi: 10.1182/blood-2011-09-377895
22. Alexander T, Thiel A, Rosen O, et al. Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood 2009;113:214-23.
23. Thiel A, Alexander T, Schmidt CA, et al. Direct assessment of thymic reactivation after autologous stem cell transplantation. Acta Haematol 2008;119:22-7. (Pubitemid 351363854)
24. Schulz KR, Danna EA, Krutzik PO, et al. Single-cell phospho-protein analysis by flow cytometry. Curr Protoc Immunol 2012;96:8.17.1-8.17.20. doi: 10.1002/0471142735. im0817s96
25. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-64.
26. Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006;203:1701-11. (Pubitemid 44036276)
27. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009;30:899-911.
28. Lacotte S, Brun S, Muller S, et al. CXCR3, inflammation, and autoimmune diseases. Ann NY Acad Sci 2009;1173:310-17.
29. Campbell JJ, O'Connell DJ, Wurbel MA. Cutting Edge: chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4T cells under physiological conditions. J Immunol 2007;178:3358-62. (Pubitemid 46417598)
30. Floess S, Freyer J, Siewert C, et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007;5:e38.
31. Kimmig S, Przybylski GK, Schmidt CA, et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 2002;195:789-94. (Pubitemid 34259723)
32. Booth NJ, McQuaid AJ, Sobande T, et al. Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO. J Immunol 2010;184:4317-26.
33. Rochman Y, Spolski R, Leonard WJ. New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol 2009;9:480-90.
34. Huang X, Guo Y, Bao C, et al. Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity. PLoS One 2011;6:e21671.
35. Hsieh CS, Liang Y, Tyznik AJ, et al. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 2004;21:267-77. (Pubitemid 39094055)
36. Pacholczyk R, Ignatowicz H, Kraj P, et al. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity 2006;25:249-59.
37. Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010;11:7-13.
38. Enghard P, Humrich JY, Rudolph B, et al. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients. Arthritis Rheum 2009;60:199-206.
39. Hoerning A, Kohler S, Jun C, et al. Peripherally Circulating CD4(+) FOXP3(+) CXCR3(+) T regulatory cells correlate with renal allograft function. Scand J Immunol 2012;76:320-8.
40. Elkord E, Sharma S, Burt DJ, et al. Expanded subpopulation of FoxP3+ T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs. Clin Immunol 2011;140:218-22.
41. Humrich JY, Morbach H, Undeutsch R, et al. Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc Natl Acad Sci USA 2010;107:204-9.
42. Munoz LE, Janko C, Schulze C, et al. Autoimmunity and chronic inflammation-two clearance-related steps in the etiopathogenesis of SLE. Autoimmun Rev 2010;10:38-42.
43. Bonelli M, Savitskaya A, Steiner CW, et al. Phenotypic and functional analysis of CD4+. J Immunol 2009;182:1689-95.